Altratech has pioneered a novel diagnostic technology that significantly enhances the detection and quantification of molecular targets such as DNA, RNA, antibodies, and antigens. This innovative process eliminates the need for traditional biological amplification methods, which are often time-consuming, by utilizing electronic signal amplification for rapid digital read-outs. The result is a new generation of portable diagnostic products that combine the ease of lateral flow tests with the high performance typically associated with laboratory PCR tests. This technology is designed for use in point-of-care settings or home environments, making it accessible and user-friendly.

The team at Altratech comprises a diverse group of scientists and engineers, including experts in molecular biology, organic and synthetic chemistry, microfluidics, and CMOS semiconductor technologies. With over 200 years of combined experience, Altratech aims to revolutionize decentralized healthcare through its high-performance diagnostics. Their commitment to superior sensitivity and specificity in molecular detection positions them at the forefront of the next generation of diagnostic solutions, enabling robust and flexible testing capabilities in various environments.

Ireland

At Altratech, we are moving serology and the monitoring of viral contagious diseases out of the laboratory to the point-of-care and community clinics.

We are a team of twenty scientists and engineers, including nine PhDs, from cross-functional backgrounds of molecular biology, organic and synthetic chemistry, microfluidics, engineering and CMOS semiconductor technologies. With over 200 years of combined experience, our vision is to create portable high-performance diagnostics which will enable the next generation of decentralised connected healthcare and wellbeing.

Altratech

Company Details